Biodexa Pharmaceuticals Plc (NAS:BDRX)
$ 0.9999 0.009899 (1%) Market Cap: 9.63 Mil Enterprise Value: 2.58 Mil PE Ratio: 0 PB Ratio: 0.86 GF Score: 45/100

Half Year 2020 Midatech Pharma PLC Earnings Call Transcript

Sep 10, 2020 / 01:00PM GMT
Release Date Price: $3136 (-4.39%)
Tim Metcalfe;IFC Advisory;Managing Director

Good afternoon from Cardiff, and welcome to the Midatech Pharma 2020 Interim Results Presentation. With me is Stephen Stamp, CEO and CFO of the company, who'll run through the presentation. At the end of the presentation, there will be a question-and-answer session. (Operator Instruction].

And with that, I will now hand over to Stephen, who will take you through the presentation. Stephen?

Stephen A. Stamp
Midatech Pharma plc - CEO, CFO & Director

Thank you, Tim, and good afternoon, everybody, in the U.K., and good morning to those joining from the U.S. I'm Stephen Stamp, CEO and CFO of Midatech. And if you want to put a face to a name, I'm in the middle of Slide 2, surrounded by the brains of the organization. I have a dozen-or-so slides today, after which, as Tim said, I'd be happy to answer any questions you may have submitted.

Moving on to Slide 3. I should like to take this slide as read, if I may, but I would encourage you to refer to our public filings, both on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot